Revision is a relatively young Canadian company which in no time has become the main supplier worldwide of ballistic eye protection.
Recently, they also became one of the main producers of helmets.
Advanced military solutions for ultimate protection and peak performance.
Revision develops and delivers purpose-built protective soldier equipment for military use worldwide.
The company, which began with eyewear, has expanded to face, head and torso protection and continues to develop their capabilities for integrated, performance-enhancing soldier systems.
To that end, Revision brings together the most advanced expertise, state-of-the-art facilities and finest technical minds. Clients include the U.S. Department of Defense, the Canadian Department of National Defence, the Netherlands Defence Materiel Organization, the Swiss Federal Department of Defence, the Danish Defense Acquisition and Logistics Organization, the German Bundeswehr and the UK Ministry of Defence.
Revision focuses on the military and tactical end user – military, police and security – with top-quality products like the Sawfly, the Stingerhawk and the Hellfly (all ballistic protection glasses), the Desert Locust, Bullet Ant, Exoshield and Wolfspider (all ballistic goggles) and the range of helmets, the Batlskin Viper and Cobra.
Revision is without any doubt the best available ballistic protection against environmental circumstances (sun and artificial light, dark, dust, dirt, etc. ), impact by fragmentation (bombsplinters, explosions, shells of bullets, etc. ), liquids, objects, ... and laser light sources (laser pens, machines, weapons, etc. ).
Revision offers the best ballistic protection (exceeding the existing norms), the best Return On Investment (lowest maintenance cost), the highest optical quality. The products are compatible with a wide variation of helmets, protection and communication means. With the prescription ready insert, wearer’s of glasses or lenses can use all the products and adapt to their eyesight. Finally, Revision scores best in almost all user trials